Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126404052 | 12640405 | 2 | F | 201604 | 20160830 | 20160810 | 20160906 | EXP | GB-AMGEN-GBRSP2016101084 | AMGEN | 41.00 | YR | A | F | Y | 0.00000 | 20160905 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126404052 | 12640405 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | 125031 | UNKNOWN FORMULATION | ||||||||
126404052 | 12640405 | 2 | SS | APREPITANT. | APREPITANT | 1 | Oral | UNK | 0 | ||||||||||
126404052 | 12640405 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK | 0 | ||||||||||
126404052 | 12640405 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 6 | SS | DOMPERIDONE | DOMPERIDONE | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 7 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 8 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 9 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 10 | SS | PALONOSETRON HYDROCHLORIDE. | PALONOSETRON HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
126404052 | 12640405 | 11 | SS | TAXOTERE | DOCETAXEL | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126404052 | 12640405 | 1 | Product used for unknown indication |
126404052 | 12640405 | 2 | Product used for unknown indication |
126404052 | 12640405 | 3 | Product used for unknown indication |
126404052 | 12640405 | 4 | Product used for unknown indication |
126404052 | 12640405 | 5 | Product used for unknown indication |
126404052 | 12640405 | 6 | Product used for unknown indication |
126404052 | 12640405 | 7 | Product used for unknown indication |
126404052 | 12640405 | 8 | Product used for unknown indication |
126404052 | 12640405 | 9 | Product used for unknown indication |
126404052 | 12640405 | 10 | Product used for unknown indication |
126404052 | 12640405 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126404052 | 12640405 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126404052 | 12640405 | Alopecia | |
126404052 | 12640405 | Ear discomfort | |
126404052 | 12640405 | Epistaxis | |
126404052 | 12640405 | Fatigue | |
126404052 | 12640405 | Haemoglobin abnormal | |
126404052 | 12640405 | Infusion site erythema | |
126404052 | 12640405 | Infusion site pruritus | |
126404052 | 12640405 | Infusion site vesicles | |
126404052 | 12640405 | Joint swelling | |
126404052 | 12640405 | Limb discomfort | |
126404052 | 12640405 | Neuropathy peripheral | |
126404052 | 12640405 | Oedema peripheral | |
126404052 | 12640405 | Pain in extremity | |
126404052 | 12640405 | Peripheral swelling | |
126404052 | 12640405 | Pyrexia | |
126404052 | 12640405 | Rosacea | |
126404052 | 12640405 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126404052 | 12640405 | 5 | 20160602 | 0 | ||
126404052 | 12640405 | 11 | 20160602 | 0 |